On May 13, 2025, the family and Nanogen Pharmaceutical Biotechnology JSC announced the passing of Dr. Ho Nhan, Chairman of the company’s Board of Directors. He passed away on May 12, 2025, at 4:25 pm at the age of 59, after a brave battle with heart disease.
Dr. Ho Nhan was born in 1966 in Thu Duc, Ho Chi Minh City. He had a strong academic background, holding a doctoral degree from the University of Arizona in the United States.
He returned to Vietnam in 2006 and embarked on a journey to establish a modern pharmaceutical biotechnology foundation.
He was also known as the son-in-law of Mrs. Nguyen Thi Son, the founder of Son Kim Group, one of the influential business families in Ho Chi Minh City.
During the Covid-19 pandemic, Dr. Ho Nhan and his team led Nanogen to become the first private entity in Vietnam to research and develop the Nanocovax vaccine against Covid-19.
Beyond biotechnology, Mr. Ho Nhan ventured into the financial sector. In April 2013, he joined the Board of Directors of Vina Securities Company during a period of losses for the company. He served on the board from April 2013 to September 2017.
While residing in the United States, he was involved in numerous mergers and acquisitions in the healthcare industry, encompassing pharmaceuticals, medical equipment, and hospitals. He also led a team responsible for valuing healthcare stocks for a Hong Kong-based investment fund with assets worth billions of dollars. He was once a major shareholder of One World Service JSC (ONW), owning 15.8% of the company’s shares as of the end of 2016.
“The legacy left by Dr. Ho Nhan includes not only scientific and technological achievements but also inspiration for young generations to dedicate themselves to serving society with knowledge and dedication,” the Nanogen statement read.
The funeral of Dr. Ho Nhan will be held according to Catholic rituals at his residence in Thu Duc City. The burial will take place on the morning of May 16, 2025, at the Phuc An Vien Cemetery in District 9, Ho Chi Minh City.
The Entrepreneurial Journey of Ho Nhan – Former Nanogen CEO and Son Kim Clan’s Son-in-Law, Remembered.
“The prominent businessman, Ho Nhan, the man behind the Nanocovax vaccine and son-in-law of the prestigious Son Kim family, has suddenly passed away. A shocking and unexpected turn of events, his death leaves a void in the business world and raises many questions.”
“Nanogen and Dr. Ho Nhahn’s COVID-19 Vaccine Endeavor: A 5,000 Billion VND ‘Made in Vietnam’ Venture.”
In 2019, KIS Securities Joint Stock Company reportedly invested nearly VND 11.6 billion to acquire 162,500 shares of Nanogen during the company’s capital raise. This transaction valued each share at over VND 71,000, as per the financial report.
The Largest Private Hospital System in the Northeastern Mountainous Provinces Unveils the Unprecedented
This business has unveiled an ambitious plan for the future, a strategy that showcases a bold and innovative vision. With a forward-thinking approach, they aim to make a significant impact and leave a lasting impression.
The Heat is On: Bank Stocks Face Potential Sell-Off as They’re Cut from VN30 Index in April’s Reshuffle
The market currently has four ETFs tracking the VN30 index, with an estimated combined asset value of nearly VND 7,800 billion.
The Market Beat on Valentine’s Day: Finance Sector Falters but VN-Index Stays in the Green
The market ended the session on a positive note, with the VN-Index climbing 5.73 points (+0.45%) to reach 1,276.08, while the HNX-Index rose 1.7 points (+0.74%) to close at 231.22. The market breadth tilted in favor of gainers, with 473 advancing stocks against 300 decliners. The large-cap sector painted a bullish picture, as evidenced by the VN30 basket, which witnessed 16 gainers, 8 losers, and 6 stocks ending unchanged, favoring the bulls.
